Improving Access to Overdose Treatment

For program and eligibility questions:
Kristen K. Harper, M.Ed.
240.276.2420
kristen.harper@samhsa.hhs.gov

For grants management and budget questions:
240.276.1400
FOACSAP@samhsa.hhs.gov

For grant review process and application status questions:
Emily Chan
240.276.2446
emily.chan@samhsa.hhs.gov

The Improving Access to Overdose Treatment program provides grants to expand access to Food and Drug Administration approved overdose reversal medications for emergency treatment of known or suspected opioid overdose. Grantees will collaborate with other prescribers at the community level to implement trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications for rural or urban populations of focus.

Required activities include:

• Implement a scalable training of trainers (ToT) program via an established ToT model either in-person, virtually, or hybrid formats
• Register trainees and secure their commitment to offer the training in their local regions
• Deliver a curriculum and provide resources to health care providers and pharmacists that includes best practice protocols for prescribing a drug or device approved by the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose
• Establish and implement protocols to connect patients who have experienced a drug overdose to appropriate treatment, including medications for opioid use disorder (MOUD) and other appropriate behavioral health services
• Develop a plan for sustaining the program after federal support for the program has ended
• Provide specific information on the ToT framework

Up to 20% of the grant may be used for the purchase of approved drugs or devices for distribution under the program.

Eligible applicants are:

• Federally Qualified Health Centers
• Opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations
• Practitioners who dispense narcotic drugs pursuant to section 303(g) of the Controlled Substances Act

Estimated award amount: $200,000 per year
Project period: Up to 5 years
Estimated number of awards: 7
Estimated total program funding: $1,400,000

Links to the full announcement, application instructions, and online application process are available through grants.gov.